Cerca per...
-
11GiuVenture Capital watch: how COVID-19 is affecting and will affect VC transactions with a specific focus on the life sciences and healthcare sectorsThe COVID-19 outbreak is affecting VC transactions all over the world. Challenges but also opportunities may arise in sectors that will shape the post–COVID-19 world.
-
-
11GiuAcquisitions of companies involved in the medical devices business fall under the Italian foreign investment controlMore than 2 months ago the Italian Government issued certain measures with the purpose of expanding its power to veto or impose conditions on acquisitions of, or other transactions involving, Italian targets operating in certain strategic sectors.
-
-
9GiuItalian Competition Authority approves two emergency cooperation projects: one for joint distribution of surgical masks and one common moratorium scheme on consumer lendingFor the first time the Italian Competition Authority applied the communication of April 24, 2020, on cooperation agreements in the context of the COVID-19 outbreak. The two cooperation projects concern the joint distribution of surgical masks and a common moratorium scheme on consumer lending.
-
-
29MagCOVID-19 emergency and processing of health data for scientific research purposesThe Italian version of this article was first published on Diritto 24 - Il Sole 24 Ore. The health emergency due to the spread of COVID-19 has made the need to correctly manage the processing of health data for scientific research purposes even more topical.
-
-
9AprCOVID-19 emergency: increasingly dematerialized prescriptionsBreaking news about e-prescriptions: Ordinance 651/2020 and Ministerial Decree of March 25, 2020 introduced alternative tools to paper memorandum of e-prescriptions.
-
-
9AprMedical Devices Regulation: EU Commission proposes a one year postponement of the application dateThe European Commission adopted a proposal to postpone the date of application of Medical Device Regulation by one year and deviate from the conformity assessment procedures in cases of emergency.Articolo inserito in: Life Sciences-Healthcare
-
-
9AprAIFA: latest indications for "remote" clinical trials during the COVID-19 health emergencyOn April 7, 2020, the Italian Medicines Agency (“AIFA”) provided guidance on the management of clinical trials in light of the restrictive measures adopted by the Government against the COVID-19 pandemic.
-
-
8AprCOVID-19 emergency: clinical trials and early access to drugsTo address the current emergency caused by COVID-19, several initiatives have been undertaken at the regulatory level to promote and facilitate clinical trials and early access to drugs.
-
-
8AprEmergenza Covid-19, ricette mediche sempre più dematerializzate: i prossimi stepL’Ordinanza del 19 marzo per limitare gli spostamenti delle persone, ha aumentato l’uso della ricetta elettronica, introducendo importanti novità nella comunicazione del promemoria. Facciamo il punto sul quadro normativo alla luce del DM del 25 marzo, che ha confermato alcune delle novità e ne ha introdotto altre
-
-
31MarCOVID-19 and consumer protection: the impact on selling and advertising practices and early reactions from relevant Italian bodiesHow coronavirus impacted sales and advertising from a practical standpoint
-
